GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: GI-87084B | Ultiva®
                                 remifentanil is an approved drug (FDA (1996)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Remifentanil is a synthetic opioid analgesic drug.
                                    
                                   View more information in the IUPHAR Pharmacology Education Project: remifentanil | 
 | |||||||||||||||||||||||||||||||||||
| No information available. | 
| Summary of Clinical Use  | 
| May be combined with other medications to induce/maintain general anesthesia and to provide analgesia in mechanically ventilated intensive care patients. | 
| Mechanism Of Action and Pharmacodynamic Effects  | 
| Agonist activity at the opioid receptors in the central nervous system (CNS) causes hyperpolarization and reduced neuronal excitability by various mechanisms. See the DrugBank link for further details. | 
| External links  | 
| For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com |